From yesterday’s decision by Judge Gregory Woods (S.D.N.Y.) in Cassava Sciences, Inc. v. Bredt: Cassava Sciences, Inc. (“Cassava”) is a biotechnology company that is conducting clinical trials for an Alzheimer’s drug called simufilam. Following the second phase of the simufilam clinical trials, multiple short sellers, most of them scientists, published concerns about the integrity of the…
Drug Company’s Libel Lawsuit Against Scientists Dismissed
Date:
More like thisRelated
Big Boom AJ, Big Justice, and the Rizzler won an AEW wrestling match. The internet loved it.
The Costco guys landed a W in televised PPV...
DC Circuit Finds Some FINRA Authority Violates Private Nondelegation Doctrine
The private nondelegation doctrine is getting an increasing amount...